Legal & General Group PLC Talaris Therapeutics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$4.51 - $9.85 $527 - $1,152	-117 Reduced 5.55%	1,991 $9,000
Q1 2022 May 16, 2022	BUY	$6.89 - $16.56 $682 - $1,639	99 Added 4.93%	2,108 $21,000
Q4 2021 Feb 14, 2022	BUY	$12.18 - $17.0 $14,019 - $19,567	1,151 Added 134.15%	2,009 $31,000
Q2 2021 Aug 12, 2021	BUY	$12.25 - $18.61 $10,510 - $15,967	858 New	858 $13,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.